What is Inari Medical Inc share price today?

Inari Medical Inc (NARI) share price today is {{live_price}}.

Can Indians buy Inari Medical Inc shares?

Yes, Indians can invest in the Inari Medical Inc (NARI) from India. With INDmoney, you can buy Inari Medical Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Inari Medical Inc at zero transaction cost.

How can I buy Inari Medical Inc shares from India?

It is very easy to buy Inari Medical Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inari Medical Inc be purchased?

Yes, you can buy fractional shares of Inari Medical Inc with INDmoney app.

What are the documents required to start investing in Inari Medical Inc stocks?

To start investing in Inari Medical Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Inari Medical Inc

Today’s highest price of Inari Medical Inc (NARI) is {{1_rba_end}}. Today’s lowest price of Inari Medical Inc (NARI) is {{1_rba_st}}.

What is today's market capitalisation of Inari Medical Inc

Today's market capitalisation of Inari Medical Inc NARI is 2.5B

What is the 52 Week High and Low Range of Inari Medical Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Inari Medical Inc is down from its 52 Week High?

Inari Medical Inc (NARI) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Inari Medical Inc is up from its 52 Week low?

Inari Medical Inc (NARI) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Inari Medical Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Inari Medical Inc

Mr. Andrew J. Hykes is the current Chief Executive Officer (CEO) of Inari Medical Inc.

Home>
US Stocks>
Inari Medical Inc

Inari Medical Inc (NARI)

$43.68

-0.55

(-1.24%)▲

Live

Performance

$43.40
$44.06
$43.68
0.64%
Downside
Day's Volatility :1.5%
Upside
0.86%
$36.73
$67.13
$43.68
15.91%
Downside
52 Weeks Volatility :45.29%
Upside
34.93%

Returns

Period	Inari Medical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-19.9%	3.6%	0.0%
6 Months	16.61%	10.2%	0.0%
1 Year	-23.01%	19.6%	0.0%
3 Years	-50.26%	16.8%	-23.0%

Highlights

Market Capitalization	2.5B
Book Value	$7.29
Earnings Per Share (EPS)	-0.99
Wall Street Target Price	64.5

Profit Margin	-10.42%
Operating Margin TTM	-10.75%

Return On Assets TTM	-2.15%
Return On Equity TTM	-13.28%

Revenue TTM	547.5M
Revenue Per Share TTM	9.47
Quarterly Revenue Growth YOY	22.5%
Gross Profit TTM	339.0M
EBITDA	-14.9M
Diluted Eps TTM	-0.99
Quarterly Earnings Growth YOY	-0.84

EPS Estimate Current Year	-0.81
EPS Estimate Next Year	0.21
EPS Estimate Current Quarter	-0.15
EPS Estimate Next Quarter	-0.1

Analyst Recommendation

Buy

82%Buy

17%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Inari Medical Inc(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 47.66%

Current $43.68

Target $64.50

Company Financials

	FY18	Y/Y Change
Revenue	6.8M	-
Net Income	-10.2M	-
Net Profit Margin	-148.67%	-

	FY19	Y/Y Change
Revenue	51.1M	↑ 648.7%
Net Income	-1.9M	↓ 81.22%
Net Profit Margin	-3.73%	↑ 144.94%

	FY20	Y/Y Change
Revenue	139.7M	↑ 173.17%
Net Income	13.8M	↓ 823.03%
Net Profit Margin	9.87%	↑ 13.6%

	FY21	Y/Y Change
Revenue	277.0M	↑ 98.31%
Net Income	9.8M	↓ 28.64%
Net Profit Margin	3.55%	↓ 6.32%

	FY22	Y/Y Change
Revenue	383.5M	↑ 38.45%
Net Income	-29.3M	↓ 397.43%
Net Profit Margin	-7.63%	↓ 11.18%

	FY23	Y/Y Change
Revenue	493.6M	↑ 28.73%
Net Income	-1.6M	↓ 94.41%
Net Profit Margin	-0.33%	↑ 7.3%

	Q1 FY23	Q/Q Change
Revenue	116.2M	↑ 7.79%
Net Income	-2.2M	↓ 61.75%
Net Profit Margin	-1.91%	↑ 3.47%

	Q2 FY23	Q/Q Change
Revenue	119.0M	↑ 2.44%
Net Income	2.1M	↓ 194.0%
Net Profit Margin	1.75%	↑ 3.66%

	Q3 FY23	Q/Q Change
Revenue	126.4M	↑ 6.19%
Net Income	3.2M	↑ 51.65%
Net Profit Margin	2.5%	↑ 0.75%

	Q4 FY23	Q/Q Change
Revenue	132.1M	↑ 4.53%
Net Income	-4.7M	↓ 247.6%
Net Profit Margin	-3.53%	↓ 6.03%

	Q1 FY24	Q/Q Change
Revenue	143.2M	↑ 8.4%
Net Income	-24.2M	↑ 418.58%
Net Profit Margin	-16.9%	↓ 13.37%

	Q2 FY24	Q/Q Change
Revenue	145.8M	↑ 1.83%
Net Income	-31.3M	↑ 29.53%
Net Profit Margin	-21.5%	↓ 4.6%

	FY18	Y/Y Change
Total Assets	26.9M	-
Total Liabilities	66.3M	-

	FY19	Y/Y Change
Total Assets	44.5M	↑ 65.59%
Total Liabilities	83.7M	↑ 26.14%

	FY20	Y/Y Change
Total Assets	214.1M	↑ 380.6%
Total Liabilities	13.8M	↓ 83.47%

	FY21	Y/Y Change
Total Assets	311.5M	↑ 45.52%
Total Liabilities	72.3M	↑ 422.71%

	FY22	Y/Y Change
Total Assets	504.2M	↑ 61.82%
Total Liabilities	87.2M	↑ 20.48%

	FY23	Y/Y Change
Total Assets	674.2M	↑ 33.74%
Total Liabilities	209.3M	↑ 140.19%

	Q1 FY23	Q/Q Change
Total Assets	506.5M	↑ 0.47%
Total Liabilities	79.8M	↓ 8.44%

	Q2 FY23	Q/Q Change
Total Assets	525.0M	↑ 3.64%
Total Liabilities	89.3M	↑ 11.94%

	Q3 FY23	Q/Q Change
Total Assets	548.8M	↑ 4.55%
Total Liabilities	96.7M	↑ 8.25%

	Q4 FY23	Q/Q Change
Total Assets	674.2M	↑ 22.85%
Total Liabilities	209.3M	↑ 116.48%

	Q1 FY24	Q/Q Change
Total Assets	661.8M	↓ 1.85%
Total Liabilities	214.5M	↑ 2.49%

	Q2 FY24	Q/Q Change
Total Assets	672.9M	↑ 1.69%
Total Liabilities	249.1M	↑ 16.12%

	FY18	Y/Y Change
Operating Cash Flow	-10.9M	-
Investing Cash Flow	-753.0K	-
Financing Cash Flow	26.8M	-

	FY19	Y/Y Change
Operating Cash Flow	-4.9M	↓ 54.68%
Investing Cash Flow	-3.1M	↑ 317.53%
Financing Cash Flow	10.2M	↓ 61.79%

	FY20	Y/Y Change
Operating Cash Flow	1.9M	↓ 138.74%
Investing Cash Flow	-55.4M	↑ 1663.26%
Financing Cash Flow	144.1M	↑ 1309.64%

	FY21	Y/Y Change
Operating Cash Flow	25.5M	↑ 1232.95%
Investing Cash Flow	-51.0M	↓ 7.96%
Financing Cash Flow	4.1M	↓ 97.17%

	FY22	Y/Y Change
Operating Cash Flow	-14.0M	↓ 154.82%
Investing Cash Flow	-195.2M	↑ 282.61%
Financing Cash Flow	177.1M	↑ 4249.08%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-2.0M	↓ 117.89%
Investing Cash Flow	-4.0M	↓ 87.84%
Financing Cash Flow	2.5M	↓ 246.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	9.8M	↓ 584.85%
Investing Cash Flow	-6.1M	↑ 50.38%
Financing Cash Flow	-2.4M	↓ 195.38%

Technicals Summary

Sell

Neutral

Buy

Inari Medical Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inari Medical Inc	2.46%	16.61%	-23.01%	-50.26%	4.05%
Stryker Corporation	0.83%	12.78%	40.21%	33.69%	71.83%
Boston Scientific Corp.	4.85%	29.48%	75.68%	96.28%	127.87%
Edwards Lifesciences Corp.	4.32%	-19.19%	1.77%	-39.29%	-7.22%
Abbott Laboratories	3.99%	11.51%	24.65%	-4.53%	46.22%
Medtronic Plc	2.65%	14.48%	27.42%	-24.18%	-13.49%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inari Medical Inc	NA	NA	NA	-0.81	-0.13	-0.02	NA	7.29
Stryker Corporation	40.15	40.15	2.64	12.01	0.19	0.07	0.01	51.86
Boston Scientific Corp.	70.26	70.26	2.14	2.41	0.09	0.05	NA	13.85
Edwards Lifesciences Corp.	27.67	27.67	3.65	2.6	0.22	0.12	NA	12.35
Abbott Laboratories	35.83	35.83	4.31	4.67	0.14	0.06	0.02	22.26
Medtronic Plc	30.23	30.23	1.67	5.2	0.08	0.04	0.03	37.39

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inari Medical Inc	Buy	$2.5B	4.05%	NA	-10.42%
Stryker Corporation	Buy	$137.1B	71.83%	40.15	16.12%
Boston Scientific Corp.	Buy	$127.3B	127.87%	70.26	12.0%
Edwards Lifesciences Corp.	Buy	$42.3B	-7.22%	27.67	23.74%
Abbott Laboratories	Buy	$205.1B	46.22%	35.83	13.65%
Medtronic Plc	Buy	$115.2B	-13.49%	30.23	12.06%

Insights on Inari Medical Inc

Increasing Revenue
Revenue is up for the last 17 quarters, 25.39M → 145.82M (in $), with an average increase of 10.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 3.16M → -31.34M (in $), with an average decrease of 231.9% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 76.0% return, outperforming this stock by 95.9%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 96.3% return, outperforming this stock by 146.6%

Institutional Holdings

BlackRock Inc
14.35%
Vanguard Group Inc
9.66%
AllianceBernstein L.P.
4.14%
State Street Corp
3.53%
Brown Advisory Holdings Inc
3.11%
Point72 Asset Management, L.P.
2.54%

Corporate Announcements

Inari Medical Inc Earnings
Inari Medical Inc’s price-to-earnings ratio stands at None
Read More

Organization	Inari Medical Inc
Employees	1300
CEO	Mr. Andrew J. Hykes
Industry	Health Technology

Inari Medical Inc (NARI)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Decreasing Net Profit

Vs BSX

Vs BSX

Institutional Holdings

Corporate Announcements

Inari Medical Inc Earnings

Company Information

Discover More

FAQs